Replies to post #133512 on Rivulet Media Inc (fka RIVU)

[NoQuarter]

Not nitpicking NEW4THIS but it is actually better for BMSN

derived from the child's own cord blood

If the child is between 2-5 years old they would have to use cord blood from other newborns.. (unless they freeze the umbilical cord blood at birth of course) However, as you said... BMSN uses cells from the patients own body to reduce rejection to...zero!
NoQuarter

[sizzleweed]

Hema II, the next beast in the pipeline after DcellVAX.


Rosy Euphoric Golden Emu Northbound

HemaXellerate II is intended to be a universal donor endothelial cell based therapeutic and is intended to be manufactured by obtaining cells from a part of the placenta called the “vascular lobules”. The cells are processed and utilized for the purpose of stimulating bone marrow hematopoetic stem cell repair and proliferation. The mechanism of action for HemaXellerate II is similar to HemaXellerate I whereby the harvested and processed cells would produce growth factors which would mediate the therapeutic effects of the product.